How a New Pill Can ‘Melt Away’ Your Leukemia Cells
A pill that “melts away” cancer cells may replace chemotherapy often used to treat relapsed chronic lymphocytic leukemia (CLL).The U.S. Food and Drug Administration (FDA) recently approved the drug, idelalisib (Zydelig™), to treat CLL.
In a recent study of the drug, researchers found that it was effective in treating patients with CLL. The study used this pill along with another drug to treat the disease.
Researchers saw improved survival rates with less severe side effects in patients who used the pill. One researcher described how it worked, saying patients’ cancer “quickly melted away.”
Idelalisib is the second new pill the FDA has approved to treat CLL in the last 12 months. The agency approved the first drug, ibrutinib (Imbruvica®), in November 2013.